MLchartDataset catalogue

Alimta

Term · Oncology and biomedicine · MLC-T-ONC-000375

A drug used alone or with other drugs to treat certain types of non-small cell lung cancer and malignant pleural mesothelioma. It is also being studied in the treatment of other types of cancer. Alimta stops cells from using folic acid to make DNA and may kill cancer cells. It is a type of antimetabolite and a type of antifolate. Also called LY231514, pemetrexed disodium, and Pemfexy.

Table 1. Record
IdentifierMLC-T-ONC-000375
FieldOncology and biomedicine
SynonymsLY231514; pemetrexed disodium; Pemfexy
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-000375",
  "term": "Alimta",
  "field": "Oncology and biomedicine",
  "definition": "A drug used alone or with other drugs to treat certain types of non-small cell lung cancer and malignant pleural mesothelioma. It is also being studied in the treatment of other types of cancer. Alimta stops cells from using folic acid to make DNA and may kill cancer cells. It is a type of antimetabolite and a type of antifolate. Also called LY231514, pemetrexed disodium, and Pemfexy.",
  "synonyms": [
    "LY231514",
    "pemetrexed disodium",
    "Pemfexy"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/alimta/"
}

Record 631 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.